Bristol-Myers Squibb Company
Companies and groups · United States
In these lists: Biggest budgets, Medicines
- Declared lobbying cost
- €2,500,000 – €2,749,999 Financial year 01/2025-12/2025
- Commission meetings
- 10
- Full-time staff on EU lobbying
- 4
- European Parliament access passes
- 7
- Registered since
- 26 Sept 2011
Public records onlyWhat this means
Every profile, record and figure comes from documents published by EU institutions, national authorities, courts, ethics bodies, the EU Transparency Register or established news outlets. We use no leaks, private data or anonymous tips. AI helps us gather and cross-check sources but never decides anyone's guilt: each record keeps its exact legal status and links to its source, so you can check it yourself
Fields of interest
Banking and financial services, Budget, Business and industry, Competition, Consumers, Customs, Digital economy and society, Economy, finance and the euro, Employment and social affairs, Environment, External relations, Institutional affairs, Justice and fundamental rights, Public health, Research and innovation, Single market, Taxation, Trade
Medicines and food topics they name
EU medicines law
EU laws and policies they declare following15
- 28th Regime for Innovative Companies
- European Innovation Act
- Public Procurement Act
- European Research Area Act
- European Biotech Act I
- European Biotech Act II
- Omnibus on taxation
- Interest and Royalties Directive (Council Directive 2003/49/EC)
- Tax Merger Directive (Council Directive 2009/133/EC)
- Parent-Subsidiary Directive (Council Directive 2011/96/EU)
- Anti-Tax Avoidance Directive (Council Directive (EU) 2016/1164)
- Tax Dispute Resolution Mechanisms Directive (Council Directive 2017/1852).
- Framework for Income Taxation (BEFIT)
- Communication on better regulation
- Update of antitrust procedural rules
Meetings with the Commission
Meetings with Commissioners or their Cabinets since 1 December 2024, as the Commission publishes them